WHO ICTRP trial
Krachttraining en eiwitsuppletie ter preventie van bijwerkingen van hormonale…
NL-OMON20332 · Overview of Medical Research in the Netherlands (NL-OMON) · Recruiting
Key facts
| Trial ID | NL-OMON20332 |
|---|---|
| Public title | Krachttraining en eiwitsuppletie ter preventie van bijwerkingen van hormonale behandeling bij mannen met prostaatkanker. |
| Scientific title | Resistance exercise training and protein supplementation to prevent side effects of androgen deprivation therapy (ADT) in men with prostate cancer |
| Primary sponsor | Maastricht University |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Conditions | prostate cancer, androgen deprivation therapy, muscle mass, resistance exercise, protein supplementation prostaatkanker, androgen deprivatie therapie, spiermassa, krachtttraining, eiwitsuppletie |
| Interventions | 3 arms: - control group that receives usual care - intervention group that receives 20 weeks of resistance exercise plus protein supplements - intervention group that receives 20 weeks of resistance exercise plus placebo supplements |
| Registration date | May 11, 2017 |
| Target size | 208 |
| Secondary IDs | NL6258;NTR6432;NL59282.068.16 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: